JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DISH
3901
PUT
DELISTED
DISH Network Corp.
DISH
| $1.45M | ﹤0.01% |
251,600
-33,000
| -12% | -$148K |
2022 Q3
5 quarters
|
|
3902
Conduent
CNDT
$257M
| $1.45M | ﹤0.01% |
397,681
+175,733
| +79% | +$556K |
2017 Q1
27 quarters
|
|
3903
PUT
Kohl's
KSS
$2.13B
| $1.45M | ﹤0.01% |
+50,600
| New | +$1.19M |
2023 Q4
0 quarters
|
|
3904
Coherus Oncology
CHRS
$179M
| $1.45M | ﹤0.01% |
435,666
-4,944,542
| -92% | -$13.2M |
2014 Q4
36 quarters
|
|
3905
Embecta
EMBC
$320M
| $1.45M | ﹤0.01% |
76,541
-20,904
| -21% | -$343K |
2022 Q2
6 quarters
|
|
|
VRN
3906
DELISTED
Veren
VRN
| $1.45M | ﹤0.01% |
208,634
+176,918
| +558% | +$1.31M |
2014 Q1
39 quarters
|
|
3907
CALL
Ameriprise Financial
AMP
$43.4B
| $1.44M | ﹤0.01% |
3,800
| – | – |
2023 Q1
3 quarters
|
|
|
GOOD
3908
Gladstone Commercial Corp
GOOD
$626M
| $1.44M | ﹤0.01% |
108,757
+16,103
| +17% | +$202K |
2013 Q3
41 quarters
|
|
3909
Banco Santander
SAN
$194B
| $1.44M | ﹤0.01% |
347,529
-13,457
| -4% | -$52.7K |
2013 Q2
42 quarters
|
|
3910
PUT
JB Hunt Transport Services
JBHT
$22B
| $1.44M | ﹤0.01% |
+7,200
| New | +$1.33M |
2023 Q4
0 quarters
|
|
3911
CALL
ArcelorMittal
MT
$48.5B
| $1.42M | ﹤0.01% |
50,000
+16,200
| +48% | +$397K |
2023 Q3
1 quarter
|
|
|
3912
PUT
ArcelorMittal
MT
$48.5B
| $1.42M | ﹤0.01% |
+50,000
| New | +$1.22M |
2023 Q4
0 quarters
|
|
3913
Enanta Pharmaceuticals
ENTA
$377M
| $1.42M | ﹤0.01% |
150,821
-46,313
| -23% | -$432K |
2016 Q1
31 quarters
|
|
3914
Sierra Bancorp
BSRR
$515M
| $1.42M | ﹤0.01% |
62,920
+6,741
| +12% | +$131K |
2013 Q2
42 quarters
|
|
|
TERN
3915
DELISTED
Terns Pharmaceuticals
TERN
| $1.42M | ﹤0.01% |
218,201
-64,934
| -23% | -$343K |
2021 Q1
11 quarters
|
|
3916
Zentalis Pharmaceuticals
ZNTL
$239M
| $1.42M | ﹤0.01% |
93,448
-8,481
| -8% | -$124K |
2020 Q2
14 quarters
|
|
3917
Franklin FTSE Japan ETF
FLJP
$4.16B
| $1.41M | ﹤0.01% |
50,525
+13,113
| +35% | +$351K |
2022 Q3
5 quarters
|
|
3918
PUT
Expeditors International
EXPD
$25B
| $1.41M | ﹤0.01% |
+11,100
| New | +$1.31M |
2023 Q4
0 quarters
|
|
3919
iShares Russell 2500 ETF
SMMD
$4.08B
| $1.41M | ﹤0.01% |
22,929
+12,090
| +112% | +$670K |
2022 Q4
4 quarters
|
|
|
X
3920
PUT
DELISTED
US Steel
X
| $1.41M | ﹤0.01% |
28,900
-263,200
| -90% | -$9.57M |
2023 Q3
1 quarter
|
|
|
DCPH
3921
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.41M | ﹤0.01% |
87,148
+4,447
| +5% | +$56.7K |
2017 Q4
24 quarters
|
|
3922
Ducommun
DCO
$2.65B
| $1.41M | ﹤0.01% |
26,993
+8,216
| +44% | +$401K |
2017 Q4
24 quarters
|
|
3923
OraSure Technologies
OSUR
$273M
| $1.4M | ﹤0.01% |
171,333
-114,707
| -40% | -$752K |
2015 Q4
32 quarters
|
|
3924
Dimensional Global Real Estate ETF
DFGR
$3.63B
| $1.4M | ﹤0.01% |
53,929
+15,900
| +42% | +$373K |
2023 Q1
3 quarters
|
|
3925
FIGS
FIGS
$2.25B
| $1.4M | ﹤0.01% |
201,470
-28,095
| -12% | -$186K |
2021 Q2
10 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.